Nyxoah Aktie
WKN DE: A2QCWK / ISIN: BE0974358906
09.07.2021 22:30:00
|
Information on the total number of voting rights and shares
REGULATED INFORMATION
Information on the total number of voting rights and shares
Mont-Saint-Guibert (Belgium), July 9, 2021, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of 435,250 new shares on July 9, 2021 pursuant to (i) a capital increase in connection with Nyxoah’s initial public offering in the United States and (ii) the exercise of subscription rights.
- Share capital: EUR 4,369,902.59
- Total number of securities carrying voting rights: 25,437,859 (all ordinary shares)
- Total number of voting rights (= denominator): 25,437,859 (all relating to ordinary shares)
- Number of rights to subscribe to securities carrying voting rights not yet issued:
- 91 "2013 ESOP Warrants” issued on 3 May 2013 and 23 December 2014, entitling their holders to subscribe to a total number of 45,500 securities carrying voting rights (all ordinary shares);
- 365 "2016 ESOP Warrants” issued on 3 November 2016, entitling their holders to subscribe to a total number of 182,500 securities carrying voting rights (all ordinary shares);
- 319 "2018 ESOP Warrants” issued on 12 December 2018, entitling their holders to subscribe to a total number of 159,500 securities carrying voting rights (all ordinary shares); and
- 540,000 "2020 ESOP Warrants” issued on 21 February 2020, entitling their holders to subscribe to a total number of 540,000 securities carrying voting rights (all ordinary shares).
*
* *
For further information, please contact:
Nyxoah
Fabian Suarez, CFO
corporate@nyxoah.com
+32 (0)10 22 24 55
Gilmartin Group
Vivian Cervantes
IR@nyxoah.com
Attachment

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Nyxoah S.A. Registered Shsmehr Nachrichten
08.04.25 |
EQS-News: Nyxoah Provides Update on FDA Approvable Letter for Genio System (EQS Group) | |
26.03.25 |
EQS-News: Nyxoah erhält Approvable Letter für sein Genio®-System von der FDA (EQS Group) | |
26.03.25 |
EQS-News: FDA Issues Nyxoah an Approvable Letter for its Genio® System (EQS Group) | |
13.03.25 |
EQS-News: Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results (EQS Group) | |
13.03.25 |
EQS-News: Nyxoah gibt Finanzergebnisse für das vierte Quartal und das Geschäftsjahr 2024 bekannt und informiert über die Unternehmensentwicklung (EQS Group) | |
12.03.25 |
Ausblick: Nyxoah vermeldet Zahlen zum jüngsten Quartal (finanzen.net) | |
26.02.25 |
Erste Schätzungen: Nyxoah gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net) | |
19.02.25 |
EQS-News: Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East (EQS Group) |
Analysen zu Nyxoah S.A. Registered Shsmehr Analysen
Aktien in diesem Artikel
Nyxoah S.A. Registered Shs | 5,49 | -5,83% |
|